Man Group PLC Bridge Bio Pharma, Inc. Transaction History
Man Group PLC
- $49.7 Billion
- Q2 2025
A detailed history of Man Group PLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Man Group PLC holds 135,425 shares of BBIO stock, worth $7.62 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
135,425
              Previous 18,148
              
        
           646.23%
        
      
          
        Holding current value
$7.62 Million
            Previous $627,000
            
        
           832.54%
        
      
          
        % of portfolio
0.01%
            Previous 0.0%
          
        Shares
	  14 transactions
	
  Others Institutions Holding BBIO
# of Institutions
408Shares Held
187MCall Options Held
11.3MPut Options Held
1.91M- 
    
      Viking Global Investors LP18.6MShares$1.04 Billion2.54% of portfolio
- 
    
      Vanguard Group Inc Valley Forge, PA16.5MShares$927 Million0.01% of portfolio
- 
    
      Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$746 Million22.63% of portfolio
- 
    
      Black Rock Inc. New York, NY12.4MShares$700 Million0.01% of portfolio
- 
    
      Janus Henderson Group PLC London, X09.28MShares$522 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $8.34B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...